Haploidentical hematopoietic stem cell transplantation and complex congenital heart disease: a treatment challenge case report
Hematol., Transfus. Cell Ther. (Impr.); 46 (1), 2024
Results: 9
The tale of two organs: allogeneic hematopoietic stem cell transplantation following liver transplantation in a myelofibrosis patient
Hematol., Transfus. Cell Ther. (Impr.); 45 (4), 2023
Natural killer cells 56bnght16- have higher counts in the umbilical cord blood than in the adult peripheral blood
Hematol., Transfus. Cell Ther. (Impr.); 45 (4), 2023
ABSTRACT Introduction and hypothesis: Umbilical cord blood (UCB) is an alternative source of hematopoietic stem cells for allogeneic hematopoietic stem cell transplantation in the absence of a compatible donor. The UCB transplantation has a lower incidence of chronic graft versus host disease (GvHD), bu...
Brazilian dental consensus on dental management in hematopoietic stem cell transplantation− Part I− pre-HSCT
Hematol., Transfus. Cell Ther. (Impr.); 45 (3), 2023
ABSTRACT The oral involvement in the Hematopoietic Stem Cell Transplantation is well described in the literature. The goal of the dental treatment and management of the oral lesions related to the HSCT is to reduce the harm caused by preexisting oral infection or even the worsening of oral acute/chronic ...
Need for hemodialysis in patients undergoing hematopoietic stem cell transplantation: risk factors and survival in a retrospective cohort
Hematol., Transfus. Cell Ther. (Impr.); 45 (3), 2023
ABSTRACT Introduction: Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) patients are exposed to acute and chronic nephrotoxic events (drugs, hypotension, infections, and microangiopathy). The need for hemodialysis (HD) may be associated with high mortality rates. However, the risk factors ...
Dentistry consensus on HSCT - Part III: Special topics - Dentistry on HSCT
Hematol., Transfus. Cell Ther. (Impr.); 45 (3), 2023
ABSTRACT Patients undergoing hematopoietic stem cell transplantation (HSCT) might present acute and late toxicities and the oral tissues are frequently affected. With the survival increasing, patients show late and long-term morbidities, and there is an important association between the general and the o...
Dental consensus on HSCT - Part II: dental Care during HSCT
Hematol., Transfus. Cell Ther. (Impr.); 45 (3), 2023
ABSTRACT During the state of immune vulnerability in hematopoietic stem cell transplantation (HSCT), the patient has an increased risk of developing a vast number of complications, including severe problems in the oral cavity. These situations require professional oral care to act in the diagnosis and tr...
Acute promyelocytic leukemia in childhood and adolescence: treatment results of a modified AIDA protocol at a Brazilian center
Hematol., Transfus. Cell Ther. (Impr.); 45 (supl.2), 2023
ABSTRACT Introduction: Acute promyelocytic leukemia currently presents an excellent chance of cure with protocols based on all-trans-retinoic acid (ATRA) and anthracycline or only differentiation agents. However, high early mortality rates continue to be reported Methods: Between 2000 and 2018, patient...
Survival benefit of pediatric-based regimen for adults with acute lymphoblastic leukemia: A single-center retrospective cohort
Hematol., Transfus. Cell Ther. (Impr.); 45 (supl.2), 2023
ABSTRACT Introduction: Improving survival of Acute Lymphoblastic Leukemia (ALL) in adult patients has been a challenge. Despite intensive chemotherapy treatment, overall survival is poor. However, several studies demonstrate that young adult patients have better survival when treated with pediatric-base...